These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 5074526)

  • 1. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM; Babbini M; Khalsa HJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
    Mattila MJ; Alhava E; Mansner R
    Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 4. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism by dopa of morphine analgesia. A hypothesis for morphine tolerance.
    Vander Wende C; Spoerlein MT
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):37-45. PubMed ID: 5030707
    [No Abstract]   [Full Text] [Related]  

  • 7. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
    Papeschi R; Randrup A
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
    [No Abstract]   [Full Text] [Related]  

  • 8. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
    Buxbaum DM; Yarbrough GG; Carter ME
    J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 10. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
    Schoenfeld RI; Seiden LS
    J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
    Etemadzadeh E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulus-dependent antagonism of the alpha-methyltyrosine-induced lowering of brain catecholamines by (+)-amphetamine in intact mice.
    Welch BL; Welch AS
    J Pharm Pharmacol; 1967 Dec; 19(12):841-3. PubMed ID: 4384230
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral and biochemical effects of alpha-methyltyrosine in cats.
    Kitsikis A; Roberge AG
    Psychopharmacologia; 1973 Jul; 31(2):143-55. PubMed ID: 4722207
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
    Attila LM; Ahtee L
    Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the development of morphine dependence and morphine tolerance in rats].
    Theiss P; Herz A; Bläsig J
    Arzneimittelforschung; 1974 Jul; 24(7):1014-5. PubMed ID: 4408044
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of dopamine and norepinephrine in the naloxone-induced abstinence of morphine-dependent mice.
    Maruyama Y; Takemori AE
    J Pharmacol Exp Ther; 1973 Jun; 185(3):602-8. PubMed ID: 4736512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.